Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331☆
David R. Spigel(Sarah Cannon), David Vicente(Hospital Universitario Virgen Macarena), Tudor–Eliade Ciuleanu(Institute of Oncology Prof. Dr. Ion Chiricuta), Scott Gettinger(Yale Cancer Center), Solange Peters(University Hospital of Lausanne), Leora Horn(Vanderbilt University), Clarisse Audigier-Valette, N. Pardo Aranda(Vall d'Hebron Institute of Oncology), Óscar Juan(Hospital Universitari i Politècnic La Fe), Ying Cheng(Jilin Province Tumor Hospital), H. Zhang(Tang Du Hospital), Meiqi Shi(Nanjing Medical University), Alexander Luft(Leningrad Regional Cancer Center), Juergen Wolf(University Hospital Cologne), Scott Antonia(Moffitt Cancer Center), Kazuhiko Nakagawa(Kindai University Hospital), Justin Fairchild(Bristol-Myers Squibb (United States)), Christine Baudelet(Bristol-Myers Squibb (United States)), Devangini K. Pandya(Bristol-Myers Squibb (United States)), Parul Doshi(Bristol-Myers Squibb (United States)), Han Chang(Bristol-Myers Squibb (United States)), Martin Reck(LungenClinic Grosshansdorf)
Cited by 268Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis